Parallel-Group Comparison of Olmesartan (OLM), Amlodipine (AML) and Hydrochlorothiazid (HCTZ) in Hypertension

NCT00923091 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2689

Enrollment

INDUSTRY

Sponsor class

Conditions

Essential Hypertension

Interventions

DRUG: olmesartan medoxomil + amlodipine + hydroclororthiazide + placebo
DRUG: Olmesartan medoxomil + amlodipine + hydrochlorothiazide + placebo
DRUG: olmesartan medoxomil + amlodipine + hydroclororthiazide
DRUG: olmesartan medoxomil + amlodipine + hydroclororthiazide
DRUG: olmesartan medoxomil + amlodipine + hydroclororthiazide
DRUG: olmesartan medoxomil + amlodipine
DRUG: olmesartan medoxomil + amlodipine
DRUG: olmesartan medoxomil + amlodipine

Sponsor

Daiichi Sankyo